Home › Atherosclerosis › Indiana › Indianapolis
Atherosclerosis clinical trials in Indianapolis, IN
4 studies for Atherosclerosis are looking for participants at sites in and around Indianapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RecruitingPhase 2
- Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
RecruitingPhase 3
- Indiana University Health Methodist Hospital, Indianapolis
- Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Indianapolis
Pharmacogenomic Informed Statin Prescribing
Recruiting
- Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Boston, MA10 studies
- Houston, TX10 studies
- Washington, DC9 studies
- Orlando, FL8 studies
- Arlington, VA8 studies
- Hialeah, FL8 studies
- Durham, NC7 studies
- Memphis, TN7 studies
- Dallas, TX7 studies
- Miami, FL7 studies
- Las Vegas, NV7 studies
- Minneapolis, MN6 studies
Other studies in Indianapolis
- Non-Small Cell Lung Cancer32 studies
- Cancer (all types)24 studies
- Heart Failure23 studies
- Breast Cancer20 studies
- Obesity20 studies
- Metastatic Cancer19 studies
- Colorectal Cancer18 studies
- Ovarian Cancer17 studies
- Lung Cancer16 studies
- Cardiovascular Disease16 studies
- Type 1 Diabetes14 studies
- Endometrial Cancer14 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.